These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients. Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG Clin Transpl; 1990; ():289-300. PubMed ID: 2103152 [TBL] [Abstract][Full Text] [Related]
9. Effective induction immunosuppression for cadaver renal transplantation at the St. Francis Regional Medical Center. Shield CF Clin Transpl; 1990; ():265-74. PubMed ID: 2129408 [TBL] [Abstract][Full Text] [Related]
10. Reversal of allograft rejection using the monoclonal antibody, Campath-1G. Friend PJ; Waldmann H; Hale G; Cobbold S; Rebello P; Thiru S; Jamieson NV; Johnston PS; Calne RY Transplant Proc; 1991 Aug; 23(4):2253-4. PubMed ID: 1908152 [No Abstract] [Full Text] [Related]
11. Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation. Alexander JW; Davies CB; First MR; Cofer BR; Munda R; Madden RL; Hariharan S; Schroeder TJ Transplant Proc; 1993 Feb; 25(1 Pt 1):485-7. PubMed ID: 8438389 [No Abstract] [Full Text] [Related]
12. Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody. Chatenoud L; Ferran C; Legendre C; Kurrle R; Kreis H; Bach JF Transplant Proc; 1990 Aug; 22(4):1787-8. PubMed ID: 2117809 [No Abstract] [Full Text] [Related]
15. Anti-LFA-1 adhesion molecule monoclonal antibody in prophylaxis of human kidney allograft rejection. Le Mauff B; Hourmant M; Le Meur Y; Dantal J; Cantarovich D; Caudrelier P; Alberici G; Soulillou JP Transplant Proc; 1995 Feb; 27(1):865-6. PubMed ID: 7879210 [No Abstract] [Full Text] [Related]
16. Cadaveric renal transplantation in the cyclosporine and OKT3 eras: an update of the University of Wisconsin-Madison experience. D'Alessandro AM; Lorentzen DF; Pirsch JD; Knechtle SJ; Reed A; Hoffmann RM; Armbrust MJ; Sollinger HW; Kalayoglu M; Belzer FO Clin Transpl; 1989; ():239-51. PubMed ID: 2487569 [TBL] [Abstract][Full Text] [Related]
17. The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis. Haberal M; Sert S; Gülay H; Arslan G; Bilgin N Transplant Proc; 1990 Aug; 22(4):1761-3. PubMed ID: 2117801 [No Abstract] [Full Text] [Related]
18. Renal function outcomes in kidney transplant recipients after conversion to everolimus-based immunosuppression regimen with CNI reduction or elimination. Cataneo-Dávila A; Zúñiga-Varga J; Correa-Rotter R; Alberú J Transplant Proc; 2009 Dec; 41(10):4138-46. PubMed ID: 20005355 [TBL] [Abstract][Full Text] [Related]
19. Comparison between prophylactic use of OKT3 and cyclosporine in cadaveric renal transplantation. De Pauw L; Abramowicz D; Goldman M; Vereerstraeten P; Kinnaert P; Toussaint C Transplant Proc; 1990 Aug; 22(4):1759-60. PubMed ID: 2117800 [No Abstract] [Full Text] [Related]